Tech Company Financing Transactions
Sagent Pharmaceuticals Funding Round
Private investors participated in a $40 million Series B funding round for Sagent Pharmaceuticals. The round was announced on 4/9/2010.
Transaction Overview
Company Name
Announced On
4/9/2010
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1901 N. Roselle Rd. 450
Schaumburg, IL 60195
USA
Schaumburg, IL 60195
USA
Phone
Website
Email Address
Overview
SAGENT is a forward-thinking specialty injectables company that goes beyond just listening to what our customers have to say. We're committed to responding to what we hear. With speed, with flexibility, and with efficiency.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Yordon
Browse more venture capital transactions:
Prev: 4/8/2010: Karmasphere venture capital transaction
Next: 4/9/2010: MedMinder Systems venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs